| 25 May 2026 |
AA Water |
5.0 |
2mg |
1.8mg |
-10.9% |
99.67% |
Lab E |
| 25 May 2026 |
AICAR |
6.0 |
10mg |
10.5mg |
+5.2% |
99.89% |
Lab B |
| 25 May 2026 |
Crystagen |
7.9 |
30mg |
25.7mg |
-14.3% |
98.46% |
Lab C |
| 25 May 2026 |
Enclomiphene |
6.9 |
25mg |
22.0mg |
-11.9% |
96.68% |
Lab D |
| 25 May 2026 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
6.8 |
100g |
105.7g |
+5.7% |
95.21% |
Lab B |
| 25 May 2026 |
Prostamax |
7.6 |
20mg |
21.4mg |
+6.9% |
95.87% |
Lab C |
| 24 May 2026 |
DSIP |
6.8 |
10mg |
11.6mg |
+16.2% |
95.12% |
Lab A |
| 24 May 2026 |
EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 |
8.8 |
100g |
90.6g |
-9.4% |
95.76% |
Lab C |
| 24 May 2026 |
GHRP-2 Acetate |
5.7 |
50mg |
54.2mg |
+8.4% |
96.66% |
Lab F |
| 24 May 2026 |
Prostamax |
7.7 |
20mg |
24.3mg |
+21.7% |
99.85% |
Lab G |
| 24 May 2026 |
Thymalin |
4.0 |
2mg |
2.2mg |
+8.3% |
98.23% |
Lab C |
| 24 May 2026 |
AA Water |
5.2 |
5mg |
6.2mg |
+23.7% |
95.48% |
Lab F |
| 24 May 2026 |
AICAR |
5.6 |
50mg |
50.3mg |
+0.7% |
96.38% |
Lab D |
| 24 May 2026 |
Cardiogen |
7.7 |
2mg |
2.2mg |
+10.8% |
96.68% |
Lab C |
| 24 May 2026 |
(2-Chloroethyl)benzene CAS 622-24-2 |
6.8 |
100g |
97.2g |
-2.8% |
95.19% |
Lab A |
| 24 May 2026 |
Oxymetholone (Anadrol) Raw |
7.6 |
100g |
104.7g |
+4.7% |
98.36% |
Lab D |
| 24 May 2026 |
P21 |
8.6 |
5mg |
6.0mg |
+20.6% |
97.20% |
Lab A |
| 24 May 2026 |
T3 (Liothyronine) |
8.1 |
50mg |
56.0mg |
+11.9% |
99.09% |
Lab F |
| 24 May 2026 |
Test Suspension |
8.9 |
250mg/ml |
282.4mg/ml |
+13.0% |
96.33% |
Lab E |
| 24 May 2026 |
Thymalin |
5.7 |
2mg |
2.0mg |
+0.1% |
98.63% |
Lab A |
| 24 May 2026 |
Crystagen |
8.5 |
20mg |
20.5mg |
+2.7% |
96.37% |
Lab B |
| 24 May 2026 |
Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) |
6.6 |
200mg/ml |
229.7mg/ml |
+14.8% |
97.13% |
Lab A |
| 24 May 2026 |
Lipo-C FAT BLASTER |
9.0 |
200mg/ml |
225.5mg/ml |
+12.8% |
98.47% |
Lab F |
| 24 May 2026 |
Superdrol Oil |
7.2 |
100mg/ml |
98.9mg/ml |
-1.1% |
98.88% |
Lab F |
| 24 May 2026 |
Tadalafil (Cialis) |
4.0 |
25mg |
25.1mg |
+0.5% |
98.68% |
Lab C |
| 24 May 2026 |
Thymalin |
5.5 |
30mg |
30.1mg |
+0.3% |
98.97% |
Lab D |
| 23 May 2026 |
Superdrol Oil |
8.1 |
250mg/ml |
255.3mg/ml |
+2.1% |
99.85% |
Lab E |
| 23 May 2026 |
Testosterone Decanoate Raw |
8.0 |
10g |
8.9g |
-10.7% |
97.99% |
Lab B |
| 23 May 2026 |
Tirzepatide 30mg Pen Kit |
6.7 |
2mg |
2.4mg |
+18.4% |
95.82% |
Lab B |
| 21 May 2026 |
AHK-CU |
8.5 |
30mg |
26.4mg |
-11.8% |
95.57% |
Lab C |
| 21 May 2026 |
S-23 Raw |
6.7 |
500g |
585.7g |
+17.1% |
95.48% |
Lab C |
| 21 May 2026 |
Tirzepatide 30mg Pen Kit |
6.5 |
2mg |
2.4mg |
+21.3% |
96.64% |
Lab A |
| 20 May 2026 |
Retatrutide |
7.5 |
5mg |
5.6mgpackage |
4.89mg |
-12.1% |
092025 |
| 20 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
5.4 |
2mg |
1.9mg |
-7.1% |
98.04% |
Lab B |
| 20 May 2026 |
Oxymetholone (Anadrol) Raw |
7.7 |
5g |
4.5g |
-9.4% |
98.65% |
Lab B |
| 20 May 2026 |
T3 (Liothyronine) |
7.5 |
20mg |
20.3mg |
+1.4% |
96.81% |
Lab E |
| 19 May 2026 |
Cardiogen |
9.9 |
2mg |
2.0mg |
+2.0% |
97.54% |
Lab E |
| 19 May 2026 |
EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 |
9.3 |
500g |
586.5g |
+17.3% |
95.48% |
Lab E |
| 17 May 2026 |
EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 |
10.0 |
500g |
530.7g |
+6.1% |
99.99% |
Lab D |
| 17 May 2026 |
GHRP-2 Acetate |
5.1 |
50mg |
47.4mg |
-5.1% |
95.92% |
Lab E |
| 17 May 2026 |
Hyaluronic acid |
8.8 |
2mg |
2.3mg |
+13.9% |
95.69% |
Lab F |
| 29 Jan 2026 |
Cardiogen |
8.7 |
5mg |
4.7mg |
-6.1% |
96.89% |
Lab G |
| 29 Jan 2026 |
Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) |
7.1 |
250mg/ml |
276.2mg/ml |
+10.5% |
98.34% |
Lab A |
| 29 Jan 2026 |
LL37 |
7.9 |
50mg |
44.4mg |
-11.2% |
98.76% |
Lab D |
| 26 Jan 2026 |
(2-Chloroethyl)benzene CAS 622-24-2 |
6.6 |
5g |
4.6g |
-8.2% |
96.08% |
Lab C |
| 26 Jan 2026 |
Enclomiphene |
6.1 |
20mg |
17.2mg |
-14.0% |
97.76% |
Lab E |
| 19 Jan 2026 |
BPC-157 Arg Oral |
5.7 |
100mg |
102.6mg |
+2.6% |
95.27% |
Lab B |
| 19 Jan 2026 |
Oxymetholone (Anadrol) Raw |
8.3 |
100g |
110.9g |
+10.9% |
99.76% |
Lab G |
| 15 Jan 2026 |
Tirzepatide |
6.8 |
10mg |
(no batch claim) |
6.53mg |
-34.7% |
0091825 |
| 9 Jan 2026 |
(2-Chloroethyl)benzene CAS 622-24-2 |
8.2 |
500g |
455.2g |
-9.0% |
96.93% |
Lab E |
| 9 Jan 2026 |
BPC-157 Arg Oral |
7.1 |
50mg |
53.6mg |
+7.2% |
96.81% |
Lab G |
| 9 Jan 2026 |
GHRP-2 Acetate |
6.6 |
30mg |
31.6mg |
+5.3% |
99.35% |
Lab F |
| 9 Jan 2026 |
S-23 Raw |
7.0 |
100g |
116.0g |
+16.0% |
95.60% |
Lab F |
| 7 Jan 2026 |
CJC-1295 With DAC |
10.0 |
30mg |
28.6mg |
-4.8% |
96.44% |
Lab F |
| 7 Jan 2026 |
Enclomiphene |
5.7 |
20mg |
20.0mg |
+0.0% |
98.40% |
Lab G |
| 6 Jan 2026 |
P21 |
9.4 |
50mg |
54.7mg |
+9.4% |
95.69% |
Lab C |
| 6 Jan 2026 |
Test Suspension |
7.5 |
100mg/ml |
85.8mg/ml |
-14.2% |
98.93% |
Lab E |
| 29 Dec 2025 |
BPC-157 Arg Oral |
7.0 |
25mg |
23.2mg |
-7.1% |
98.47% |
Lab C |
| 29 Dec 2025 |
DSIP |
6.6 |
15mg |
17.8mg |
+18.4% |
95.54% |
Lab D |
| 29 Dec 2025 |
Thymalin |
7.2 |
5mg |
5.1mg |
+1.9% |
98.04% |
Lab D |
| 29 Dec 2025 |
Tirzepatide 30mg Pen Kit |
6.8 |
2mg |
1.9mg |
-4.1% |
96.64% |
Lab A |
| 12 Dec 2025 |
(2-Chloroethyl)benzene CAS 622-24-2 |
6.3 |
1g |
1.0g |
+2.7% |
95.28% |
Lab G |
| 12 Dec 2025 |
Enclomiphene |
6.5 |
50mg |
53.5mg |
+6.9% |
96.18% |
Lab G |
| 12 Dec 2025 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
5.4 |
5mg |
5.6mg |
+12.4% |
98.46% |
Lab B |
| 12 Dec 2025 |
Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) |
6.8 |
100mg/ml |
109.1mg/ml |
+9.1% |
99.54% |
Lab E |
| 23 Nov 2025 |
AHK-CU |
8.8 |
10mg |
10.1mg |
+0.9% |
96.89% |
Lab A |
| 23 Nov 2025 |
LL37 |
7.2 |
5mg |
6.2mg |
+23.6% |
98.66% |
Lab A |
| 23 Nov 2025 |
S-23 Raw |
8.7 |
500g |
584.6g |
+16.9% |
97.50% |
Lab A |
| 23 Nov 2025 |
Superdrol Oil |
8.1 |
250mg/ml |
268.4mg/ml |
+7.4% |
96.53% |
Lab G |
| 17 Nov 2025 |
DSIP |
6.8 |
5mg |
4.4mg |
-11.3% |
97.92% |
Lab G |
| 17 Nov 2025 |
Tadalafil (Cialis) |
4.0 |
100mg |
108.3mg |
+8.3% |
98.94% |
Lab A |
| 14 Nov 2025 |
BPC-157 Arg Oral |
7.1 |
25mg |
30.1mg |
+20.6% |
96.45% |
Lab F |
| 5 Nov 2025 |
ARA-290 |
8.5 |
5mg |
5.7mg |
+14.3% |
97.77% |
Lab E |
| 5 Nov 2025 |
Crystagen |
7.6 |
5mg |
4.6mg |
-8.0% |
97.23% |
Lab D |
| 5 Nov 2025 |
Tirzepatide 30mg Pen Kit |
7.1 |
2mg |
2.0mg |
-0.2% |
96.76% |
Lab F |
| 4 Nov 2025 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
4.1 |
100g |
113.3g |
+13.3% |
97.91% |
Lab F |
| 17 Oct 2025 |
EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 |
9.7 |
1g |
0.9g |
-5.3% |
95.86% |
Lab F |
| 17 Oct 2025 |
Lipo-C FAT BLASTER |
6.3 |
300mg/ml |
298.2mg/ml |
-0.6% |
98.25% |
Lab B |
| 9 Oct 2025 |
ARA-290 |
8.6 |
50mg |
44.2mg |
-11.6% |
97.86% |
Lab G |
| 3 Oct 2025 |
ARA-290 |
8.4 |
10mg |
9.2mg |
-8.1% |
98.44% |
Lab F |
| 3 Oct 2025 |
Cardiogen |
4.5 |
50mg |
51.5mg |
+3.1% |
95.88% |
Lab E |
| 3 Oct 2025 |
Lipo-C FAT BLASTER |
8.2 |
200mg/ml |
216.5mg/ml |
+8.2% |
98.54% |
Lab E |
| 10 Sep 2025 |
Semaglutide |
7.3 |
20mg |
23.8mglabel |
19.7mg |
-17.3% |
000176 |
| 10 Sep 2025 |
Tirzepatide |
10.0 |
15mg |
(no batch claim) |
15.7mg |
+4.7% |
000256 |
| 10 Sep 2025 |
Tirzepatide |
6.9 |
10mg |
11.9mgwebsite |
10.4mg |
-12.2% |
000256 |
| 10 Sep 2025 |
Semaglutide |
7.4 |
5mg |
5.7mgwebsite |
5.1mg |
-10.3% |
00256 |
| 31 Aug 2025 |
Tirzepatide |
8.0 |
5mg |
(no batch claim) |
4.77mg |
-4.6% |
00256 |